文献速递临床试验与 GCP基础与转化研究

姜黄素与锌联合补充对超重或肥胖糖尿病前期患者血糖、血脂及炎症和抗氧化生物标志物影响的研究方案:随机双盲安慰剂对照2期临床试验

Evaluation of the effect of curcumin and zinc co-supplementation on glycemic measurements, lipid profiles, and inflammatory and antioxidant biomarkers in overweight or obese prediabetic patients: a study protocol for a randomized double-blind placebo-controlled phase 2 clinical trial.
PubMed 文献 · Trials · 2020-11-30

该研究为随机双盲安慰剂对照2期临床试验方案,计划纳入84例BMI 25-35的糖尿病前期患者,随访3个月,评估姜黄素与锌联合补充对血糖、血脂、炎症及抗氧化标志物的影响。研究假设联合补充可能协同延缓向2型糖尿病进展。

要点

  • 姜黄素与锌联合补充在糖尿病前期患者中尚无临床试验。
  • 方案计划评估血糖、血脂、炎症及抗氧化标志物等多维度指标。
  • 联合补充与减重饮食可能协同延缓向2型糖尿病进展。

核心结论

  • 姜黄素与锌联合补充可能通过协同效应延缓糖尿病前期向2型糖尿病进展,但需本试验验证。

研究设计与样本

  • 随机双盲安慰剂对照2期临床试验,计划纳入84例BMI 25-35的糖尿病前期患者,随访3个月(90天)。
  • 研究在Yazd糖尿病研究诊所(Shahid Sadoughi医科大学)开展,受试者为18-50岁男性或18岁至绝经前女性。

关键数值与推荐

  • 纳入标准为糖尿病前期且BMI 25-35,男性18-50岁,女性18岁至绝经前。
  • 主要评估指标包括血糖测量、血脂谱、炎症和抗氧化生物标志物;次要指标包括肝酶、血清锌、尿锌、血压、人体测量参数、生活质量、依从性、副作用、体力活动和膳食摄入。

临床怎么用

  • 目前尚无证据支持临床常规使用姜黄素与锌联合补充用于糖尿病前期管理,需等待试验结果。

局限性

  • 该文为研究方案,尚未报告实际试验结果。
  • 样本量84例,随访3个月,结论需更大规模多中心试验验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The prevalence of prediabetes is increasing worldwide. Unfortunately, prediabetes is related to non-communicable diseases. A high risk of developing type 2 diabetes mellitus (T2DM) is reported in people with prediabetes. Curcumin, a polyphenol, might lead to its therapeutic role in obesity and some obesity-related metabolic diseases. Zinc is a trace element that plays a key role in the synthesis and action of insulin, carbohydrate metabolism, and decreasing inflammation. There has been no clinical trial of zinc and curcumin co-supplementation in patients with prediabetes. In previous studies, the single administration of zinc or curcumin has not been conducted on many of the studied markers in prediabetic patients. METHODS: The purpose of this randomized double-blind placebo-controlled clinical trial is to investigate the effect of curcumin and zinc co-supplementation on glycemic measurements, lipid profiles, and inflammatory and antioxidant biomarkers among 84 prediabetic patients with body mass index (BMI) between 25 and 35. Also, liver enzyme, serum zinc, urine zinc, blood pressure, anthropometric parameters, quality of life, adherence to co-supplementation, the side effects of co-supplementation, physical activity, and dietary intake will be assessed. Women or men (18-50 years old for men and 18 years to before menopause for women) will be followed for 3 months (90 days). This study will be conducted at Yazd Diabetes Research Clinic, Shahid Sadoughi University of Medical Sciences. DISCUSSION: A diet rich in antioxidants, polyphenols, and phytochemicals has been shown to have a beneficial role in prediabetes. According to the beneficial properties of curcumin or zinc and inadequate evidence, RCTs are needed to assess the effect of curcumin and zinc co-supplementation in native prediabetes patients. We hope the results of the present trial, negative or positive, fill this gap in the literature and facilitate the approach for a much larger, multi-center clinical trial. In conclusion, a synergic effect of co-supplementation along with a weight-loss diet may delay the progression to type 2 diabetes mellitus. TRIAL REGISTRATION: Iranian Registry of Clinical Trials (IRCT) IRCT20190902044671N1 . Registered on 11 October 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Karandish M, Mozaffari-Khosravi H, Mohammadi SM, et al. Evaluation of the effect of curcumin and zinc co-supplementation on glycemic measurements, lipid profiles, and inflammatory and antioxidant biomarkers in overweight or obese prediabetic patients: a study protocol for a randomized double-blind placebo-controlled phase 2 clinical trial. Trials. 2020. PMID: 33256795. doi:10.1186/s13063-020-04923-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。